GlycoMimetics Stock (NASDAQ: GLYC) stock price, news, charts, stock research, profile.
Open | $0.283 |
Close | $0.299 |
Volume / Avg. | 2.713M / 1.497M |
Day Range | 0.283 - 0.310 |
52 Wk Range | 0.256 - 3.530 |
Market Cap | $19.339M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 22 |
Short Interest | 13.62% |
Days to Cover | 6.25 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of GlycoMimetics (NASDAQ: GLYC) through any online brokerage.
Other companies in GlycoMimetics’s space includes: Vincerx Pharma (NASDAQ:VINC), CERo Therapeutics Hldgs (NASDAQ:CERO), Serina Therapeutics (AMEX:SER), Galecto (NASDAQ:GLTO) and Imunon (NASDAQ:IMNN).
The latest price target for GlycoMimetics (NASDAQ: GLYC) was reported by HC Wainwright & Co. on Monday, May 6, 2024. The analyst firm set a price target for 0.00 expecting GLYC to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for GlycoMimetics (NASDAQ: GLYC) is $0.3 last updated May 17, 2024 at 7:46 PM EDT.
There are no upcoming dividends for GlycoMimetics.
GlycoMimetics’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for GlycoMimetics.
GlycoMimetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.